[go: up one dir, main page]

DK1583748T3 - Fremgangsmåde til fremstilling af 1,2-dichlorethanfrie krystaller af zonisamid og særdeles rene krystaller af zonisamid - Google Patents

Fremgangsmåde til fremstilling af 1,2-dichlorethanfrie krystaller af zonisamid og særdeles rene krystaller af zonisamid

Info

Publication number
DK1583748T3
DK1583748T3 DK03815138.7T DK03815138T DK1583748T3 DK 1583748 T3 DK1583748 T3 DK 1583748T3 DK 03815138 T DK03815138 T DK 03815138T DK 1583748 T3 DK1583748 T3 DK 1583748T3
Authority
DK
Denmark
Prior art keywords
zonisamide
crystals
dichloroethane
preparation
extremely pure
Prior art date
Application number
DK03815138.7T
Other languages
English (en)
Inventor
Yoshikazu Ueno
Yasujiro Kimura
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32711361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1583748(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of DK1583748T3 publication Critical patent/DK1583748T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03815138.7T 2003-01-13 2003-07-28 Fremgangsmåde til fremstilling af 1,2-dichlorethanfrie krystaller af zonisamid og særdeles rene krystaller af zonisamid DK1583748T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34060103A 2003-01-13 2003-01-13
PCT/JP2003/009530 WO2004063174A1 (en) 2003-01-13 2003-07-28 Process for the preparation of 1,2-dichloroethane free crystals of zonisamide and the highly pure crystals of zonisamide

Publications (1)

Publication Number Publication Date
DK1583748T3 true DK1583748T3 (da) 2010-04-19

Family

ID=32711361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03815138.7T DK1583748T3 (da) 2003-01-13 2003-07-28 Fremgangsmåde til fremstilling af 1,2-dichlorethanfrie krystaller af zonisamid og særdeles rene krystaller af zonisamid

Country Status (15)

Country Link
US (3) US20050080269A1 (da)
EP (1) EP1583748B1 (da)
KR (1) KR101004187B1 (da)
CN (1) CN100528849C (da)
AT (1) ATE457304T1 (da)
AU (1) AU2003249010A1 (da)
CY (1) CY1110007T1 (da)
DE (1) DE60331257D1 (da)
DK (1) DK1583748T3 (da)
ES (1) ES2338871T3 (da)
IL (1) IL169451A (da)
PT (1) PT1583748E (da)
SI (1) SI1583748T1 (da)
TW (1) TWI331035B (da)
WO (1) WO2004063174A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060188569A1 (en) * 2005-01-21 2006-08-24 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of zonisamide and methods for their manufacture
EP1913935A1 (en) * 2005-01-21 2008-04-23 Teva Pharmaceutical Industries Ltd Stable pharmaceutical formulations of zonisamide and methods for their manufacture
US7268234B2 (en) * 2005-09-16 2007-09-11 Dainippon Sumitomo Pharma Co., Ltd. Method for sulfonation of 1,2-benzisoxazole-3-acetic acid
CN104059120A (zh) * 2014-05-27 2014-09-24 上海新华联制药有限公司 一种高纯度倍他米松醋酸酯制备工艺

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6033114B2 (ja) 1976-12-16 1985-08-01 大日本製薬株式会社 １，２−ベンズイソキサゾ−ル誘導体
US4172896A (en) * 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
FR2428033A1 (fr) 1978-06-09 1980-01-04 Dainippon Pharmaceutical Co Nouveaux derives heterocycliques de methanesulfonamide utiles notamment comme anticonvulsivants et leur procede de preparation
JPS54163823A (en) 1978-06-12 1979-12-26 Dainippon Pharmaceutical Co Antiiepileptic agent based on 33sulphamoylmethyll 1*22benzisoxazole
JPS54163570A (en) 1978-06-12 1979-12-26 Dainippon Pharmaceutical Co Benzooxazole derivative
US4533764A (en) 1984-03-29 1985-08-06 The Dow Chemical Company Purification of bisphenols by removing residual solvent
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
JPS63150220A (ja) 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US5082669A (en) 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
US5811547A (en) 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
TW350757B (en) * 1994-11-03 1999-01-21 Ciba Geigy Ag Benzisoxazole derivatives and pesticidal compositions containing them
AU5066101A (en) 2000-04-13 2001-10-30 Synthon B.V. Modified release formulations containing a hypnotic agent
WO2003002116A1 (en) * 2001-06-29 2003-01-09 Elan Pharmaceuticals, Inc. Zonisamide use in headache
JP2005506980A (ja) 2001-08-30 2005-03-10 テバ ファーマシューティカル インダストリーズ リミティド ゾニスアミド中間体及び合成
MXPA04008109A (es) * 2002-02-22 2004-11-26 Teva Pharma Metodo para preparar cloruro de bencisoxasol metano sulfonilo y su amidacion para formar zonisamida.

Also Published As

Publication number Publication date
HK1081555A1 (en) 2006-05-19
TWI331035B (en) 2010-10-01
WO2004063174A1 (en) 2004-07-29
EP1583748B1 (en) 2010-02-10
IL169451A (en) 2010-12-30
PT1583748E (pt) 2010-03-03
KR101004187B1 (ko) 2010-12-24
US6900333B2 (en) 2005-05-31
EP1583748A4 (en) 2006-12-06
SI1583748T1 (sl) 2010-03-31
DE60331257D1 (de) 2010-03-25
US20040138473A1 (en) 2004-07-15
KR20050098862A (ko) 2005-10-12
US20050080269A1 (en) 2005-04-14
EP1583748A1 (en) 2005-10-12
CN100528849C (zh) 2009-08-19
AU2003249010A1 (en) 2004-08-10
CN1720239A (zh) 2006-01-11
TW200412341A (en) 2004-07-16
ES2338871T3 (es) 2010-05-13
US20040138474A1 (en) 2004-07-15
CY1110007T1 (el) 2015-01-14
ATE457304T1 (de) 2010-02-15

Similar Documents

Publication Publication Date Title
NO20062339L (no) Hepatitt C virus-inhibitoerer
BR0308261A (pt) Métodos extrativos para puruficação de sucralose
NO20052071L (no) Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer.
NO20062267L (no) Hepatitt C virus inhibitorer
BRPI0610312B8 (pt) dispositivo de assistência à caminhada
TW200637559A (en) 3-propenylcefem derivative
TW200613543A (en) Aqueous resist stripper composition
EA200500348A1 (ru) N-арилпиперидинзамещенные бифенилкарбоксамиды в качестве ингибиторов секреции аполипопротеина b
UA98130C2 (ru) Способ очистки газовой смеси, содержащей оксид азота (i)
CY1110007T1 (el) Μεθοδος παρασκευης κρυσταλλων ζονισαμιδης απηλλαγμενων απο 1,2-διχλωροαιθανιο και κρυσταλλοι ζονισαμιδης με πολυ υψηλο βαθμο καθαροτητας
ATE375338T1 (de) Verfahren zur aufreinigung von lanzoprazol
TW200631948A (en) High-purity alicyclic diepoxy compound, process for producing the same
ATE442354T1 (de) Pyrrolidinderivate als oxytocin antagonisten
GT200400195A (es) Nuevo proceso para reducir el nivel de impurezas en una muestra de mesotriona
NO20050871L (no) 6-amino-1H-indazol- og 4-aminobenzofuranforbindelser som fosfodiesterase 4-inhibitorer
ITMI20042413A1 (it) Processo per la preparazione di galantamina bromidrato
DE50305762D1 (de) 3,3,4,4-tetrafluorcyclopentanverbindungen als komponenten flüssigkristalliner medien
DE60312953D1 (de) Stabiles lansoprazol, enthaltend mehr als 500 ppm bis zu 3000 ppm wasser und mehr als 200 ppm bis zu 5000 ppm alkohol
NO20070776L (no) Forbedret prosess for fremstilling av mirtazapin
BR0311590A (pt) Agonistas de brs-3 não-peptìdicos
JP2008540413A5 (da)
DE602004009306D1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
NO20053208D0 (no) Metode for reduktiv dehalogenering.
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
NO20080461L (no) Solvat av kabergolin og preparater av kobergolin form I